LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Tumor Necrosis Factor Displays Anti-Inflammatory Behavior in Rheumatoid Arthritis

By LabMedica International staff writers
Posted on 09 Jun 2011
The proinflammatory protein tumor necrosis factor (TNF) has been found to have an additional, previously unsuspected anti-inflammatory function that might be coopted for treatment of chronic inflammatory conditions such as rheumatoid arthritis.

Investigators at the Hospital for Special Surgery (New York, NY, USA) worked with an in vitro model in which human monocytes and macrophages - cells that have a key role in inflammatory diseases - were treated with TNF and then challenged with LPS (lipopolysaccharide), a potent inflammatory factor that stimulates receptors important in inflammation.

They reported in the May 22, 2011, online edition of the journal Nature Immunology that TNF suppressed the inflammatory response of the macrophages and monocytes. Furthermore, in a set of in vivo experiments they found that mice treated with low doses of TNF were protected from subsequent lethal high doses of LPS. Suppression of the inflammatory response by TNF involved the protein GSK3 (glycogen synthase kinase 3-alpha) as well as the TNFAIP3 gene, which encodes the A20 protein.

"We think it is relevant to rheumatoid arthritis, not only because the cells we are studying (the macrophages) are exactly the same cells that migrate into joints and make the inflammatory cytokines involved in rheumatoid arthritis, but because A20 is involved," said senior author Dr. Lionel Ivashkiv, associate chief scientific officer at the Hospital for Special Surgery. "TNFAIP3 is one of the best linked genes to rheumatoid arthritis. There are polymorphisms in the A20 gene that have been linked to rheumatoid arthritis pathogenesis."

"Prior to this study, TNF has long been known as a potent proinflammatory cytokine, but if you look carefully through the literature, there are hints that it also has some suppressive functions, but nothing was known about the mechanisms," said Dr. Ivashkiv. "This is really the first mechanism showing how TNF can turn inflammation down."

Related Links:
Hospital for Special Surgery


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Urine Chemistry Control
Dropper Urine Chemistry Control

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more